Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in takeda pharmaceutical

Japan's Takeda To Import 50 Million Doses Of Moderna's COVID-19 Vaccine, Raises Profit Forecast

Takeda will be responsible for securing regulatory approval for the vaccine, known as mRNA-1273, with supply starting in the first half of 2021, Takeda said in a release.

Read More

Takeda To Sell Japan Consumer Health Unit Valued At $2.3 Billion To Blackstone

Japan's largest pharmaceuticals company has been reducing its OTC assets worldwide as it seeks to refocus its business and reduce debt following its $59 billion acquisition of Shire.

Read More

Japan's Takeda Expects $200 Million Operating Loss Related To Novartis' Xiidra Withdrawal

Takeda sold Xiidra to Novartis for $3.4 billion upfront and up to an additional $1.9 billion in potential milestone receipts.

Read More

Takeda India Donates Rs 1.2 Cr To PM CARES Fund

The contribution to the Fund aims to support patients and the government to contain the spread of the disease, the company said in a statement.

Read More

Japan's Takeda Plans To Sell Consumer Health Unit For Around $3.7 Billion - Nikkei

Takeda's shares rose 2.5% in Tokyo trading versus a 0.8% drop in the broader market.

Read More

Zydus Cadila Ties Up With Takeda To Develop Chikungunya Vaccine

Cadila Healthcare says the terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in the future

Read More